, The Premier Vertical Hubsite For The Life Sciences Industry, Raises $14 Million

- Oversubscribed Round of Venture Capital Allows Company to Choose Leading Investors in Plan to Dominate Life Science Content, Community And E-Commerce -

SAN FRANCISCO, Aug. 16 /PRNewswire/ -- Inc. today announced it has secured $14 million in venture capital funding from Alloy Ventures, Brentwood Venture Capital, Sanderling Ventures and Sofinnova Ventures. This significant investment will enable the company to further accelerate the aggressive pace of its growth into the premier vertical hubsite for the life sciences industry.

"Our goal is to rapidly build into the highest quality and most comprehensive life sciences service on the Internet, offering a wealth of information, community access, and e-commerce," said Jennifer King, founder of "Our new venture capital partners broaden our strengths by adding global experience and know-how in both information technology and the life sciences industry. We fully expect our newly combined team will take our company's many past successes and expand on them to produce the leading vertical portal in the industry."

Launched on March 15, 1995, ( is the leading business-to-business vertical hubsite for the life sciences industry., Inc. serves the industry's four basic needs: the need for capital, people, information, and products & services. BioSpace fulfills these needs by connecting industry professionals, investors, patients and physicians to the tools they need to make better decisions, faster. The Company was founded in 1985 by Jennifer King and for ten years focused on promoting bioscience hotbed communities via traditional publishing and interactive media. Today, delivers an Internet solution for the 160,000 industry professionals who view over 1,000,000 pages a month of continuously updated news, company profiles, stocks, jobs, events, regional hotbed communities and an ever-expanding online marketplace led by BioSpace Supplies!

The round of funding was led by Sanderling,, a leading venture firm dedicated to building successful biomedical companies. Other premier investors in the financing include Alloy Ventures (previously Asset Management),, Brentwood Venture Capital, and Sofinnova Ventures,

Joining the Board of Directors are Alloy Ventures' Craig Taylor, Brentwood's Brian Atwood and Sanderling's James L. Healy, M.D., Ph.D. These investors join current board members, Founders Jennifer C. King and Timothy C. Fredel, as well as Peninsula Capital's Greg Penner and Integrity Partners' Scott Walchek (previously VP of Shopping at Inktomi). "These new additions to our board of directors will add the perspective of an experienced venture investor, a successful biotechnology executive and an accomplished biomedical scientist," said Timothy Fredel.

Sanderling Ventures

" has done a phenomenal job attracting members, aggregating relevant resources and promoting brand loyalty. This globe-spanning solution for both the corporate enterprise and individual executives, scientists, and investors is poised to become the E-market maker of the biopharmaceutical community worldwide," said Sanderling's Dr. James Healy. "We are pleased to add to our portfolio of leading biomedical companies. has all the ingredients of success -- a strong loyal following, premier customers, and high quality content and commerce in a growing market that's largely untapped," concluded Healy.

Brentwood Venture Capital

"BioSpace is uniquely positioned as the first and only true vertical portal in this market as they connect the life sciences professional and the enterprise to critical resources including global news, research, supplies, services, capital, financial information and high quality talent," said Brian Atwood of Brentwood Venture Capital.

Mr. Atwood was previously a founder and President/CEO of Glycomed, a public drug discovery and development company. Brentwood has been directly involved in the creation of not only life science companies, but well known Internet, computer and communication companies.

Alloy Ventures

" complements our technology and life science portfolio of top notch companies," said Craig Taylor of Alloy Ventures. "As a vertical portal, is positioned to help life science companies revolutionize discovery in the coming biotech century as BioSpace delivers content, community and commerce from a single destination."

Sofinnova Ventures

"Our US and European connections will help us create significant value for," said Mike Powell, Managing Director of Sofinnova Ventures. " is a global brand and complements our strengths in Europe. We are excited about extending the brand to every life science professional in the world."

Biomedical companies backed by this investor syndicate include Advanced Cardiovascular Systems (Eli Lilly & Co.), Amgen, Applied BioSystems (Perkin Elmer), Aviron, CombiChem, Coulter Pharmaceuticals, Depotech (Skyepharma), IDEC Pharmaceuticals, Perclose (Abbott Labs), Regeneron, Ventritex (St. Jude), Vical and XOMA. Representative information technology investments include Apple Computer, Actel Corp., Cirrus Logic, Portola (Netscape), eMusic, Sapient (Healtheon),, WebTV and now,

"We are thrilled to have selected these venture firms that in aggregate have over 100 years of investing experience and have provided financial and strategic support to over 500 companies," said founder Jennifer C. King.


Help employers find you! Check out all the jobs and post your resume.

Back to news